% Expired Patents = 50.0

Forward Citations = 43

Loading Chart...

2 inventors (with patents filed for the assignee):

Debra Ellies (4 out of 29 patents)

William S Rosenberg (3 out of 7 patents)

4 patents: Sort by Forward Citations

1. 8198292 - Vinpocetine and eburnamonine derivatives for promoting bone growth, treating renal damage and cancer, and devices thereof (2012-06-12),

2. 8188065 - Boldine compounds for promoting bone growth (2012-05-29),

3. 8178099 - Methods of altering bone growth by administration of sost or wise antagonist or agonist (2012-05-15),

4. 8080575 - Gamma-lactam compounds for promoting bone growth (2011-12-20),

Company Overview

Osteogenex, Inc. is a biotechnology company focused on developing novel therapeutics for bone and tissue regeneration. Our innovative approach combines advanced research in molecular biology with cutting-edge technologies to address unmet medical needs in orthopedics and beyond. With a dedicated team of scientists and medical professionals, Osteogenex is committed to improving patient outcomes and quality of life through the development of new treatments for bone-related disorders.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#20 in Kansas City, KS

#560 in Kansas

#60,641 in US

Kansas City, KS, United States of America

Osteogenex, Inc.

Forward Citations = 43

2 inventors:

Debra Ellies (4 out of 29 patents)

William S Rosenberg (3 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Osteogenex, Inc.. Retrieved from https://idiyas.com/company/osteogenex

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]